文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

1979至2017年美国镰状细胞病相关死亡率趋势

Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
PubMed 文献 · Ann Emerg Med · 2020-01-01
一句话结论1979至2017年美国黑人镰状细胞病相关死亡:儿童年死亡率下降、成人上升,中位死亡年龄从28岁升至43岁,死因由急性转向慢性并发症。

该研究利用1979至2017年美国死亡率数据,以国际疾病分类编码识别镰状细胞病相关死亡,因其他种族罕见而聚焦黑人死者,计算年龄别和年均死亡率并将死因归为20类,按种族、性别、年龄组和死亡年份匹配后与非镰状细胞病相关死亡比较。1979至2017年美国黑人中共报告25665例镰状细胞病相关死亡;期间儿童年死亡率下降、成人上升,中位死亡年龄从28岁升至43岁;感染和脑血管并发症等急性死因在较年轻年龄组更常见,慢性并发症在成人更常见;镰状细胞病相关死亡更常与急性心脏、肺和脑血管并发症、急性感染、慢性心脏和肺部并发症及肾脏疾病相关,较少与药物过量和慢性感染相关。作者结论认为镰状细胞病相关死亡现在更可能与慢性并发症而非急性并发症相关,因患者寿命延长,需更多关于慢性并发症预防和治疗的研究。

要点

  • 1979至2017年美国黑人中共报告25665例镰状细胞病相关死亡,期间中位死亡年龄从28岁升至43岁。
  • 儿童镰状细胞病相关年死亡率下降,成人上升。
  • 感染、脑血管并发症等急性死因在较年轻年龄组更常见,慢性并发症在成人更常见。
  • 镰状细胞病相关死亡更常与急性心脏、肺和脑血管并发症、急性感染、慢性心脏和肺部并发症及肾脏疾病相关,较少与药物过量和慢性感染相关。
  • 作者结论:镰状细胞病相关死亡现在更可能与慢性并发症而非急性并发症相关,需更多关于慢性并发症预防和治疗的研究。

适用人群与场景

  • 美国黑人镰状细胞病相关死亡者,数据来源为1979至2017年美国死亡率数据。
  • 分析聚焦黑人死者,因镰状细胞病相关死亡在其他种族罕见。

研究设计与关键结果

  • 研究类型为基于美国死亡率数据的趋势分析,1979至2017年美国黑人中共报告25665例镰状细胞病相关死亡。
  • 期间儿童镰状细胞病相关年死亡率下降、成人上升,中位死亡年龄从28岁升至43岁。
  • 急性死因如感染和脑血管并发症在较年轻年龄组更常见,慢性并发症在成人更常见。
  • 按种族、性别、年龄组和死亡年份匹配后,镰状细胞病相关死亡更常与急性心脏、肺和脑血管并发症、急性感染、慢性心脏和肺部并发症及肾脏疾病相关,较少与药物过量和慢性感染相关。

证据类型、等级与局限

  • 证据类型:基于美国死亡率数据的趋势分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为镰状细胞病相关死亡现在更可能与慢性并发症而非急性并发症相关。
  • 作者认为因镰状细胞病患者寿命延长,需更多关于慢性并发症预防和治疗的研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We provide an updated assessment of trends in sickle cell disease (SCD)-related mortality, a significant source of mortality in the United States among black persons, using 1979 to 2017 US mortality data.

METHODS: SCD-related deaths were identified with International Classification of Diseases codes. Because SCD-related death is rare in other races, the analysis focused on black decedents. Age-specific and average annual SCD-related death rates were calculated. Causes of death codes were categorized into 20 groups relevant to SCD outcomes. SCD-related deaths were compared with non-SCD-related deaths after matching on race, sex, age group, and year of death.

RESULTS: There were 25,665 SCD-related deaths reported among blacks in the United States from 1979 through 2017. During that period, the annual SCD-related death rate declined in children and increased in adults, and the median age at death increased from 28 to 43 years. Acute causes of death, such as infection and cerebrovascular complications, were more common in younger age groups. Chronic complications were more common in adults. SCD-related deaths were more likely to be related to acute cardiac, pulmonary, and cerebrovascular complications; acute infections; and chronic cardiac and pulmonary complications and renal disorders; and less likely to be related to drug overdose and chronic infections than non-SCD-related deaths.

CONCLUSION: These data indicate SCD-related deaths are now more likely to be related to chronic complications of the disease than to acute complications. More research regarding prevention and treatment of chronic complications of SCD is necessary because persons with SCD are living longer.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Payne AB, Mehal JM, Chapman C, et al. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017. Ann Emerg Med. 2020. PMID: 32928459. doi:10.1016/j.annemergmed.2020.08.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。